Outrage has spread online that Afghan refugees entering the United States will receive the drug ivermectin although it does not have U.S. approval as a COVID-19 treatment. However, the posts miss the vital context that refugees are given ivermectin for infections unrelated to the novel coronavirus. The claims originated on Twitter when users shared a screenshot from the U.S. Centers for Disease Control and Prevention (CDC) website saying that all Middle Eastern, Asian, North African, Latin American, and Caribbean refugees should receive ivermectin two days before departure to the United States (here). Internet archives suggest the page first appeared on...
